Investigate the Development and Progression of Lung Disease in Rheumatoid Arthritis Over Time
- Conditions
- Rheumatoid ArthritisLung Diseases
- Registration Number
- NCT03616158
- Lead Sponsor
- National Jewish Health
- Brief Summary
The purpose of this study is to investigate the link between the lungs and rheumatoid arthritis (RA). Additionally, to understand why RA patients get lung disease, how to treat, and prevent the disease.
- Detailed Description
This study is to learn more about the risk factors for the development of lung disease among patients with rheumatoid arthritis (RA), an auto-immune disease. Additionally, those at heightened risk of developing RA such as in the pre-RA period. This is a prospective and retrospective study, which 420 patients will be enrolled into the study. In-person participation will be up to 4 years, completing different standard of care assessments yearly. Additionally, quality of life questionnaires will be completed every 6 months at 4 time points. Lastly, an extended follow-up will be performed yearly for an additional 6 years, an overall 10 year participation.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 340
- Age 18 - 80 years
- Subjects who do not speak English
- Subjects without the capacity to sign the informed consent form (ICF)
- Pregnant women
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Define which patients with RA (or pre-RA) are at greatest risk for developing RA-related lung disease (LD). 10 years
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
National Jewish Health
🇺🇸Denver, Colorado, United States